XML 19 R8.htm IDEA: XBRL DOCUMENT v3.24.3
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Paid-in Capital
Retained Earnings
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2022   71,618,000        
Beginning balance at Dec. 31, 2022 $ 1,607,775 $ 7,162 $ 1,377,802 $ 423,863 $ (13,019) $ (188,033)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Comprehensive income (loss) 50,252     74,490   (24,238)
Stock based compensation expense (in shares)   30,000        
Stock based compensation expense 10,290   10,290      
Common stock transactions related to stock based employee benefit plans (in shares)   713,000        
Common stock transactions related to stock based employee benefit plans 4,316 $ 74 5,258   (1,016)  
Repurchase of common stock (in shares)   (3,000)        
Repurchase of common stock (45)   (45)      
Issuance of common stock, pursuant to acquisition (in shares)   12,792,000        
Issuance of common stock, pursuant to acquisition 410,738 $ 1,279 409,459      
Conversion of options, pursuant to acquisition 10,304   10,304      
Dividends on common stock (45,236)     (45,236)    
Increase (decrease) in shares during period (in shares)   13,532,000        
Increase (decrease) in stockholders' equity during period 440,619 $ 1,353 435,266 29,254 (1,016) (24,238)
Ending balance (in shares) at Sep. 30, 2023   85,150,000        
Ending balance at Sep. 30, 2023 2,048,394 $ 8,515 1,813,068 453,117 (14,035) (212,271)
Beginning balance (in shares) at Jun. 30, 2023   85,086,000        
Beginning balance at Jun. 30, 2023 2,054,032 $ 8,509 1,809,431 437,087 (14,171) (186,824)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Comprehensive income (loss) 5,967     31,414   (25,447)
Stock based compensation expense (in shares)   30,000        
Stock based compensation expense 3,194   3,194      
Common stock transactions related to stock based employee benefit plans (in shares)   34,000        
Common stock transactions related to stock based employee benefit plans 585 $ 6 443   136  
Dividends on common stock (15,384)     (15,384)    
Increase (decrease) in shares during period (in shares)   64,000        
Increase (decrease) in stockholders' equity during period (5,638) $ 6 3,637 16,030 136 (25,447)
Ending balance (in shares) at Sep. 30, 2023   85,150,000        
Ending balance at Sep. 30, 2023 $ 2,048,394 $ 8,515 1,813,068 453,117 (14,035) (212,271)
Beginning balance (in shares) at Dec. 31, 2023 84,861,498 84,861,000        
Beginning balance at Dec. 31, 2023 $ 2,108,086 $ 8,486 1,808,883 467,305 (16,710) (159,878)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Comprehensive income (loss) 121,609     86,901   34,708
Stock based compensation expense 10,233   10,233      
Common stock transactions related to stock based employee benefit plans (in shares)   620,000        
Common stock transactions related to stock based employee benefit plans 972 $ 128 1,934   (1,090)  
Repurchase of common stock (in shares)   (40,000)        
Repurchase of common stock (880)       (880)  
Dividends on common stock (46,170)     (46,170)    
Increase (decrease) in shares during period (in shares)   580,000        
Increase (decrease) in stockholders' equity during period $ 85,764 $ 128 12,167 40,731 (1,970) 34,708
Ending balance (in shares) at Sep. 30, 2024 85,441,001 85,441,000        
Ending balance at Sep. 30, 2024 $ 2,193,850 $ 8,614 1,821,050 508,036 (18,680) (125,170)
Beginning balance (in shares) at Jun. 30, 2024   85,299,000        
Beginning balance at Jun. 30, 2024 2,130,381 $ 8,530 1,815,800 492,805 (18,744) (168,010)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Comprehensive income (loss) 73,491     30,651   42,840
Stock based compensation expense 4,128   4,128      
Common stock transactions related to stock based employee benefit plans (in shares)   142,000        
Common stock transactions related to stock based employee benefit plans 1,270 $ 84 1,122   64  
Dividends on common stock (15,420)     (15,420)    
Increase (decrease) in shares during period (in shares)   142,000        
Increase (decrease) in stockholders' equity during period $ 63,469 $ 84 5,250 15,231 64 42,840
Ending balance (in shares) at Sep. 30, 2024 85,441,001 85,441,000        
Ending balance at Sep. 30, 2024 $ 2,193,850 $ 8,614 $ 1,821,050 $ 508,036 $ (18,680) $ (125,170)